Scientists have identified a molecule that can reprogram the brain's immune cells to better fight Alzheimer's disease, reducing toxic plaques and improving memory in animal studies.
The Research
Researchers led by José Vicente Sánchez Mut at the Institute for Neurosciences in Spain and Johannes Gräff at EPFL in Switzerland discovered that a molecule called OLE, derived from the PM20D1 gene, can restore the protective function of microglia, the brain's immune cells. In Alzheimer's, microglia gradually become less effective at clearing beta-amyloid plaques. The study, published in Cell Death and Disease, showed that OLE shifts microglia into a more protective state.
In mouse models of Alzheimer's, mice treated with OLE for three months performed better on memory tests and had fewer beta-amyloid plaques compared to untreated mice. Single-cell analysis revealed that microglia were the cells most strongly affected. The treated microglia moved toward plaques and surrounded them, limiting their contact with neurons. Additional experiments in nematode worms (C. elegans) showed that OLE reduced protein aggregates and improved movement.
Why It Matters
Alzheimer's affects millions worldwide, and current treatments only manage symptoms. This research points to a new therapeutic approach that could potentially slow or reverse disease progression by harnessing the brain's own immune system. The finding that microglia can be reprogrammed offers hope for interventions that target the underlying pathology rather than symptoms.
What You Can Do
While this research is still in early stages, you can support brain health by staying mentally active, eating a Mediterranean diet, exercising regularly, and getting enough sleep. Cognitive training, like the exercises offered on iqgenio.com, may also help maintain mental sharpness.
Source: ScienceDaily Mind & Brain
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
